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Neural stem/precursor cells in the adult brain reside in the subventricular zone (SVZ) of the
lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus in the hippocampus.
These cells primarily generate neuroblasts that normally migrate to the olfactory bulb
(OB) and the dentate granule cell layer respectively. Following brain damage, such as
traumatic brain injury, ischemic stroke or in degenerative disease models, neural precursor
cells from the SVZ in particular, can migrate from their normal route along the rostral
migratory stream (RMS) to the site of neural damage. This neural precursor cell response
to neural damage is mediated by release of endogenous factors, including cytokines
and chemokines produced by the inflammatory response at the injury site, and by the
production of growth and neurotrophic factors. Endogenous hippocampal neurogenesis
is frequently also directly or indirectly affected by neural damage. Administration of
a variety of factors that regulate different aspects of neural stem/precursor biology
often leads to improved functional motor and/or behavioral outcomes. Such factors
can target neural stem/precursor proliferation, survival, migration and differentiation into
appropriate neuronal or glial lineages. Newborn cells also need to subsequently survive
and functionally integrate into extant neural circuitry, which may be the major bottleneck
to the current therapeutic potential of neural stem/precursor cells. This review will cover
the effects of a range of intrinsic and extrinsic factors that regulate neural stem/precursor
cell functions. In particular it focuses on factors that may be harnessed to enhance the
endogenous neural stem/precursor cell response to neural damage, highlighting those
that have already shown evidence of preclinical effectiveness and discussing others that
warrant further preclinical investigation.
Keywords: neural stem cell (NSC), neural precursor cell (NPC), neural stem/precursor cell (NSPC), neurogenesis,
gliogenesis, traumatic brain injury, ischemic stroke, subventricular zone (SVZ)
INTRODUCTION
The concept that the adult mammalian brain contains popula-
tions of resident neural stem/progenitor cells (hereafter collec-
tively referred to as NSPCs) was generally accepted two decades
ago (Reynolds and Weiss, 1992; Richards et al., 1992), although
first shown by Altman and Das in 1965 (Altman and Das, 1965).
Adult neurogenesis occurs primarily in two neurogenic regions in
the brain, the subventricular zone (SVZ) of the lateral ventricles
and the subgranular zone (SGZ) of the dentate gyrus in the hip-
pocampus. To produce new neurons a NSPC must go through
a process of proliferation, migration, differentiation, and inte-
gration to become a productive member of existing circuitry in
the brain. Under normal physiological conditions adult NSPCs
predominantly produce neurons, in particular interneurons in
the olfactory bulb (OB) for SVZ-derived cells and dentate gyrus
granule cell neurons for SGZ-derived cells. Following neural dam-
age, however, SVZ-derived cells have the capacity to respond to
the insult and produce neurons as well as astrocytes and oligo-
dendrocytes. Harnessing this ability of NSPCs to produce new
neuronal and glial cells as a means to replace cells damaged or
lost following neural injury or disease to promote neural repair
has been the focus of a substantial body of research. There are
four main areas in the life cycle of a NSPC that can be targeted
to try to enhance neural repair, namely proliferation, migra-
tion, differentiation (and specific cell type generation), and sur-
vival/integration. However, the field is full of conflicting reports
on the benefit and ability of NSPCs to recover function following
a range of injuries and diseases. While many labs have reported
an increase in proliferation of neuroblasts and even migration
to injured areas, a large part of the problem may lie in the fail-
ure of newly generated neurons to integrate into existing neural
circuitry and survive past 4 weeks or so after their generation.
Augmentation of all steps of the process of neurogenesis would
ideally lead to an increased benefit following injury, but ultimately
the cells must integrate and survive to have a functional benefit.
This review will cover some of the main factors known to be
involved in neurogenesis and gliogenesis in the adult CNS and
in particular those that have been shown to play a role in neural
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repair. It will also explore how inflammatory mediators and other
injury-related factors may modify the NSPC response to neural
damage. We will not undertake a comprehensive review of factors
regulating neurogenesis and gliogenesis in the normal developing
or adult brain, as there have been several recent and compre-
hensive reviews covering this area (e.g., Guillemot, 2007; Ming
and Song, 2011; Faigle and Song, 2012). Rather, we will highlight
factors that play a role in regulation of normal adult NSPC func-
tion and which have been shown to be modulated to enhance
repair following neural damage. Table 1 summarizes the factors
discussed, which NSPC populations are affected (SVZ or SGZ),
the type of neural injury, if any and the NSPC function affected.
Figure 1 depicts the effects of extrinsic factors on the SVZ-derived
NPC response to injury.
NSPC FATE: NORMAL NEUROGENIC NICHES vs. THE INJURED CNS
ENVIRONMENT
Although the bulk of neurogenesis and gliogenesis occurs during
embryonic and early postnatal development, NSPCs continue to
produce neural cells in the adult brain. Importantly for the pur-
pose of harnessing adult NSPCs for neural repair, unlike during
development, the vast majority of adult-derived cells are fated to a
neuronal lineage, with a much smaller percent differentiating into
oligodendrocytes in the normal adult brain. In general, the diver-
sity of cell types and neuronal subtypes that can be spontaneously
generated by adult NSPCs is substantially limited compared to
embryonic cells. This is probably largely due to a less permis-
sive adult environment rather than a constitutive feature of the
NSPCs themselves, as under appropriate conditions, such as in
neurospheres in vitro (Reynolds and Weiss, 1992) or following
ablation of neuronal populations without inflammatory system
activation (Magavi et al., 2000), the ability of adult NSPCs to pro-
duce different neural cell types has been demonstrated. The more
restricted fate of adult NSPCs in the normal adult CNS reflects the
relative paucity of growth and neurotrophic factors compared to
during development. The presence of inhibitory/attractive sub-
strates, such as in the RMS, to constrain migratory routes and
the lack of available space in the adult circuitry to allow integra-
tion of newborn cells, in general restricts normal NSPC function
to neurogenic regions and currently limits the ability of endoge-
nous NSPCs to replace specific neuronal or glial types in different
regions in the CNS.
To further complicate matters, the injured adult CNS is an
entirely different environment to the normal adult neurogenic
niche or the developing nervous system, with substantial influ-
ence on NSPC function that in some instances appear to override
the normal program of NSPC fate. This is particularly the case
for SVZ NSPCs, which, as detailed further below, can be induced
away from their normal migratory route to the OB toward the
site of neural damage, a process largely induced by inflamma-
tory mediators. After successful migration to the correct location,
new neuroblasts must differentiate into the proper phenotype of
neuron and integrate into local circuitry. The local circuitry to
be repaired will depend on the type of damage, be it ischemic,
traumatically injured or neurodegenerative, with some common
factors and others specific to the site and type of damage. Effects
of exogenous factors have been variably examined in each of the
above types of neural damage and are described below for the
relevant factors.
The majority of research on ectopic migration and neural dif-
ferentiation of SVZ-derived NSPCs following neural damage has
been performed by use of ischemia models and has demonstrated
that cells do indeed reach the injured parenchyma (Arvidsson
et al., 2002; Parent et al., 2002; Jin et al., 2003; Sundholm-
Peters et al., 2005; Ohab et al., 2006; Yamashita et al., 2006;
Cayre et al., 2009; Young et al., 2011). It appears that the cells
in general no longer migrate in a chain formation and carry on
individually, with some reports describing an increase in pro-
genitor numbers without an effect on numbers of cells in the
RMS (Zhang et al., 2001b), while others report that the response
to injury is at the expense of the RMS population (Jin et al.,
2003; Goings et al., 2004). This change in migration is the direct
result of chemoattractive cues expressed from the injury site. As
detailed further below, chemokines and their receptors can attract
neuroblasts from the RMS. For example, Stromal cell-derived
factor-1/CXCL12 and its receptor CXCR4 are upregulated at the
injury site (Imitola et al., 2004; Robin et al., 2006) and expression
of several other chemokines and their receptors are upregulated
on adult NSPCs by inflammatory cytokines, such as IFNγ and
TNFα (Turbic et al., 2011).
In general ischemia models have demonstrated production
of new neurons from the SVZ in damaged cortex or striatum,
while injury of the cortex usually promotes the generation of
astrocytes and microglia/macrophages at the site of injury, with
few or no new neurons produced (Ramaswamy et al., 2005;
Richardson et al., 2007; Kreuzberg et al., 2010; Blizzard et al.,
2011; Zhang et al., 2011). Neurodegenerative disease models,
such as Parkinson’s disease (PD) models, have also demonstrated
migration of SVZ NPCs to the site of damage, with production
of neurons in some cases but not others (Cooper and Isacson,
2004; Kadota et al., 2009; Jing et al., 2012). The production of
astrocytes and oligodendrocytes near the injury site may be a
result of expression of repressors of neuronal fate (Kernie et al.,
2001; Shear et al., 2004; Buffo et al., 2005). Further, as detailed
below, administration of a variety of factors promotes neuroge-
nesis and/or gliogenesis in these normally non-neurogenic sites.
The SVZ-derived NSPC response and the new cells they produce
is quite variable, depending on injury type, region of neural dam-
age, species and likely a range of other factors that remain to be
defined.
There is little/no evidence that SGZ hippocampal NSPCs can
migrate away from their normal GCL fate; however they do
respond to neural damage (Dash et al., 2001; Chirumamilla et al.,
2002), even if the hippocampus is not directly affected by damage,
such as in cortical impact models (Kernie et al., 2001). This leads
to alterations in neurogenesis that can produce altered cognition
and/or effects on memory and anxiety. Little is currently known
about how this neurogenesis is altered, but will be touched on
below.
TRANSCRIPTION FACTOR REGULATION OF NSPC FUNCTION
Factors intrinsic to the cell participate in multiple roles of neu-
rogenesis from proliferation to differentiation. Generally, tran-
scription factors are the most widely studied intrinsic factors
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Table 1 | Extrinsic factors affecting SVZ and SGZ NSPC responses under basal conditions and following neural damage.
Factor SVZ SGZ Injury/Disease Neurogenesis/
Gliogenesis
Selected references
P M D S P M D S
EGF    X Stroke, TBI Both-variable (Teramoto et al., 2003; Sun
et al., 2010)
EGF+/−FGF2    Ischemia, TBI, PD N (Nakatomi et al., 2002;
Tureyen et al., 2005; Winner
et al., 2008; Sun et al., 2009)
ATP  *(Suyama et al., 2012)
VEGF   *(Wittko et al., 2009; Calvo
et al., 2011)
IGF1    N (SGZ) *(Aberg et al., 2000; Cheng
et al., 2001)
NGF  Ischemia N (Zhu et al., 2011)
BDNF     Ischemia, TBI N (Gao and Chen, 2009; Im
et al., 2010)
Wnt (β-catenin)  ? ?  Ischemia, TBI, AD both (He and Shen, 2009; White
et al., 2010; Shruster et al.,
2012)
Shh   Ischemia, SCI both (Bambakidis et al., 2003, 2012;
Sims et al., 2009; Wang et al.,
2009)
BMPs (noggin)     Demyelination TBI,
intra-ventricular
hemorrhage
BMP: A, Noggin:
N and O
(Hampton et al., 2007; Cate
et al., 2010; Dummula et al.,
2011; Sabo et al., 2011; Lei
et al., 2012)
Epo     X Stroke, TBI, PD N and O (Tsai et al., 2006; Wang et al.,
2006; Kadota et al., 2009;
Meng et al., 2011; Ning et al.,
2011; Xiong et al., 2011; Zhang
et al., 2012)
SOCS2   N *(Turnley et al., 2002;
Ransome and Turnley, 2008b)
Chemokines     (Imitola et al., 2004; Gordon
et al., 2009)
Eph/ephrins    TBI, ischemia, PD N (Theus et al., 2010; Doeppner
et al., 2011; Jing et al., 2012)
Nitric oxide   Ischemia *(Packer et al., 2003; Park
et al., 2003; Moreno-Lopez
et al., 2004)
(Zhang et al., 2001a; Zhu
et al., 2003; Sun et al., 2005b)
Endo-cannabinoids     N *(Aguado et al., 2005, 2007;
Jiang et al., 2005; Goncalves
et al., 2008; Gao et al., 2010;
Hill et al., 2010; Wolf et al.,
2010; Oudin et al., 2011a,b)
PSA-NCAM,
Slit-Robo, integrins
 *(Cremer et al., 1994; Hu
et al., 1996; Jacques et al.,
1998; Wu et al., 1999; Chazal
et al., 2000; Murase and
Horwitz, 2002)
Reelin   Demyelination N-migration (Courtes et al., 2011)
(Continued)
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Table 1 | Continued
Factor SVZ SGZ Injury/Disease Neurogenesis/
Gliogenesis
Selected references
P M D S P M D S
Vasculature  Ischemia N-migration (Ohab et al., 2006; Yamashita
et al., 2006; Thored et al.,
2007; Kojima et al., 2010)
NMDA receptors    N *(Platel et al., 2010; Namba
et al., 2011)
P, Proliferation; M, Migration; D, Differentiation; S, Survival; N, Neurogenesis; O, Oligodendrogliogenesis; A, Astrogliogenesis; TBI, traumatic brain injury;
PD, Parkinson’s disease; AD, Alzheimer’s disease; SCI, spinal cord injury; *references for basal non-injury conditions.
researched in adult NSPCs and many are similar to programs for
neurogenesis during development. However, while a substantial
amount of information is known about the role that different
transcription factors play in modulation of NSPC biology, much
less is known about extrinsic factors that can be used to alter
expression of the transcription factors to produce desired spe-
cific functional outcomes. This section will discuss the expression
and roles of some transcription factors that may be useful ther-
apeutic targets. Later sections will discuss effects of different
extrinsic growth factors and cytokines, with particular reference
to their role following neural damage, although there are cur-
rently few links described between these factors and expression
of specific transcription factors in the adult NSPC or newborn
neural cells.
SVZ
Under basal conditions, NSPCs produced in the SVZ go on to
form neuroblasts that migrate from the lateral ventricles along
the rostral migratory stream (RMS) to the OB where they differ-
entiate into neurons of the OB. The formation and proliferation
of NSPCs is dependent on the Sox family of genes, in particular
Sox2. The zinc-finger protein Ars2 (arsenite-resistant protein 2)
controls the multipotent progenitor state of NSCs through acti-
vation of Sox2 (Andreu-Agullo et al., 2012). c-Myb is required
for maintenance of the neural stem cell niche, promoting expres-
sion of Sox2 and Pax6 and subsequent proliferation (Malaterre
et al., 2008). Epigenetic pathways can also control proliferation;
recently phosophorylation of the histone H2AXwhich was shown
to limit proliferation and overall neurogenesis (Fernando et al.,
2011). New neurons migrating from the RMS to the OB pri-
marily become GABAergic granule neurons that provide lateral
inhibition between mitral and tufted cells. A minority of the new
neurons become periglomerular neurons that are involved in lat-
eral inhibition between glomeruli, and a small number of these
cells are dopaminergic. This differentiation is under transcrip-
tional control and proneural basic-helix-loop-helix (bHLH) tran-
scription factors control neuronal fate commitment in NSPCs.
For example, type C cells of the SVZ fated to become GABAergic
interneurons in the OB express Ascl1 (Kim et al., 2007).Ngn2 and
Tbr2 are expressed in dorsal SVZ progenitors that become gluta-
matergic juxtaglomerular neurons (Brill et al., 2009), while Sp8
is required for parvalbumin-expressing interneurons in the OB
(Li et al., 2011). Dopaminergic periglomerular cells in the OB
express Pax6 and Dlx-2 (Doetsch et al., 2002; Hack et al., 2005;
Brill et al., 2008).
SGZ
Hippocampal neurogenesis involves radial and horizontal NPCs
first transitioning to intermediate progenitors and then on to
immature dentate granule neurons. When the new neurons
mature they make large mossy fiber projections with CA3 pyra-
midal neurons (Freund and Buzsaki, 1996). Sox2 has a role in
maintaining the precursor pool via Sonic hedgehog (Shh) in adult
SGZ and a role in proliferation of NPCs along with Pax6 and
CCAAT/enhancer binding protein β (C/EBPβ) (Maekawa et al.,
2005; Favaro et al., 2009; Ehm et al., 2010). Transcription factors
have a large role in the differentiation of SGZ NSPCs. Neurog2
and Tbr2 are expressed in NSCs destined to become glutamatergic
neurons in the hippocampus (Kim et al., 2007, 2011a; Ozen et al.,
2007), while over-expression of Ascl1 produces oligodendrocytes
(Jessberger et al., 2008).
Intrinsic factors are also necessary for the maturation and sur-
vival of newly born neurons. For example, Prox1 (Lavado et al.,
2010), NeuroD (Gao et al., 2009b; Kuwabara et al., 2009), and
Kruppel-like factor 9 (Scobie et al., 2009) play important roles in
survival, while cyclic response element binding protein (CREB)
signaling is required for maturation and integration into the
network. Interestingly, CREB activates miR-132 which regulates
dendrite maturation in newborn dentate gyrus granular neurons
(Magill et al., 2010). There is limited knowledge of the changes
in SGZ intrinsic factors following injury; however neurogenesis
is increased in the SGZ following injury. Following ischemia this
increase can result from an upregulation of phosphorylated CREB
(Boneva and Yamashima, 2012). In a primate model of ischemia,
pro-neuronal transcription factors are expressed including Emx2,
Pax6, and Ngn2 (Tonchev and Yamashima, 2006). Intriguingly,
in models of neurodegeneration SGZ proliferation is decreased;
as shown in a rat model of Huntington’s disease, SGZ progen-
itor cell proliferation is decreased due to an increase in Sox2-
positive quiescent stem cells and a decrease in CREB signaling
(Kandasamy et al., 2010).
Thus, many transcription factors have been shown to play a
role in NSPC function, though few have been directly targeted
by infusion of exogenous factors as a means to promote spe-
cific in vivo NSPC function and fate. Will this even be possible
in vivo without genetic modification, such as by use of viral
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FIGURE 1 | Factors that when administered to the brain following
neural damage regulate neural precursor cell responses. (A) Basal,
non-damage conditions. Inset (A.1) depicts the two main neurogenic
regions of the adult rodent brain, the subventricular zone (SVZ) and the
hippocampus. The enlarged area bounded by the box in (A.1) depicts the
general structure of the SVZ, which contains proliferative neural precursor
cells (NPCs) that differentiate into neuroblasts that then migrate along the
rostral migratory stream (RMS) to the olfactory bulb. Following neural injury
(B) the inflammatory response induces astrocytic gliosis, microglial
activation, and leukocyte infiltration from the periphery. Together, these
produce a variety of chemokines, cytokines and other factors that can lead
to the proliferation of the NPCs in the SVZ and redirect their migration to
sites of damage. Once at or near the site of damage (C) these cells can
differentiate into astrocytes, oligodendrocytes and astrocytes, depending
upon which factors are administered. Unlike the normal predominance of
neuronal differentiation under basal conditions, following injury SVZ NSPCs
can generate neurons, astrocytes and/or oligodendrocytes. (D) Following
differentiation cells need to survive and appropriately integrate into existing
circuitry. This is a large bottleneck in harnessing the therapeutic potential of
NSPCs, as the majority of newborn neurons die within a few weeks of their
generation. For correct function, many new neurons also need to be
appropriately myelinated although at present, few if any factors are known
that enhance the final myelination stage of oligodendrocyte maturation
following neural damage. Factors that have been shown to regulate the
various stages of the NPC response when administered following neural
injury are listed in blue text.
expression vectors? In many cases, particular exogenous factors
were chosen for in vivo examination based on their known effects
on induction of desired transcription pathways in other systems.
However, in most instances, only single factors have been infused.
This is in contrast to work being performed in the embryonic
stem (ES) cell and induced pluripotent stem (iPS) cell field, in
which specific transcription factors are induced by addition of
extrinsic factors for defined periods of time and in a specific
sequence to allow production of desired neural cell types. For
example, such a system has been used to generate floor plate
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cells which can subsequently generate mesencephalic dopamin-
ergic neurons (Denham et al., 2012). Of course, such specific
transcriptional regulation by exogenous factors is possible in
the highly defined ES/iPS tissue culture environment but much
more difficult in vivo, where there are many competing endoge-
nous factors regulating NSPC function under normal conditions
and even more so following neural injury. Further, the ques-
tion of which transcription factors would be worth targeting for
potential therapeutic effects is still open. Promoting a glial vs.
a neuronal fate is relatively easy; for example infusion of BMP4
induces SMAD1/5/8 phosphorylation and subsequent astroglial
fate (Cate et al., 2010). Induction of specific neuronal fates has
largely not been addressed. SVZ NSPCs predominantly generate
OB interneurons under normal conditions; however following
neural injury the SVZ NSPCs can alter their normal fate, even
in the absence of exogenous factor delivery, to become glial cells
or adopt the specific neuronal type lost due to damage, such as
striatal medium spiny neurons (Parent et al., 2002). Therefore,
factors in the local damaged environment may be sufficient to
direct final neuronal fate under some conditions, suggesting that
adult SVZNSPCs are not necessarily fate restricted and that defin-
ing factors to induce specific transcription factors, such as bHLH
proneural genes, may be beneficial.
EXTRINSIC FACTORS THAT REGULATE NSPC FUNCTION
FOLLOWING NEURAL DAMAGE
While many extracellular factors, ranging from growth factors to
morphogens to extracellular matrix to cell:cell/receptor-mediated
interactions have been shown to play a role in adult NSPC biology
in vitro and/or in vivo, some have been more well characterized
than others. This section will cover the predominant factors, as
well as some less well characterized factors, shown to regulate nor-
mal adult NSPC biology and those shown to play a role following
neural damage.
GROWTH FACTORS
Following ischemia and traumatic brain injury, expression
of various growth factors such as epidermal growth factor
(EGF), brain-derived neurotrophic factor (BDNF), nerve growth
factor (NGF), fibroblast growth factor 2 (FGF2), glial cell
line-derived neurotrophic factor (GDNF), insulin-like growth
factor 1 (IGF-1), pituitary adenylate cyclase-activating polypep-
tide (PACAP), and vascular endothelial growth factor (VEGF)
are increased and modulate neurogenesis and NSPC biology.
Additional exogenous application further augments NSPC pro-
liferation and sometimes survival (Watanabe et al., 2004; Baldauf
and Reymann, 2005; Tureyen et al., 2005; Dempsey and Kalluri,
2007; Schabitz et al., 2007; Johanson et al., 2011; Lu et al., 2011).
This section will focus on factors that have been shown to regu-
late NSPC responses in vivo and commence with an examination
of two of the most potent mitogens for increasing numbers of
NSPCs, EGF, and FGF2.
EGF
EGF is a NSPC mitogen that is commonly used to promote
neurosphere growth and maintenance in cell culture (Reynolds
and Weiss, 1992). Neurospheres are primarily derived from the
transit-amplifying (Type C) progenitor cells in the SVZ that
normally produce the neuroblasts that migrate to the OB. These
cells express the EGF receptor (EGFR) and when exposed to
exogenous EGF can be induced to a multi-potent state capable
of generating neuronal and glial cells (Doetsch et al., 2002).
Local production of EGF in the SVZ appears to be required for
normal maintenance of the proliferative NSC pool in the SVZ,
and this expression is maintained by dopaminergic innervation
of striatal neurons (O’Keeffe et al., 2009; O’Keeffe and Barker,
2011). Activation of dopamine receptors using the dopamine
receptor agonist pramipexole (PPX) augmented neurogenesis in a
PD model by upregulating expression of the EGFR (Winner et al.,
2009). Furthermore, the injury-induced proliferative response of
SVZ NSPCs at least partly involves upregulation of the EGFR
on these cells, thus enhancing their responsiveness to EGF
(Alagappan et al., 2009). However, transforming growth factor
alpha (TGFα), which also binds to the EGFR, is expressed at
higher levels in the adult brain than EGF (Seroogy et al., 1993)
and so TGFα may be the normal ligand for regulating NSPC
function in vivo.
Given the mitogenic properties of EGF for NSPCs, infusion
of EGF into the lateral ventricles following neural damage has
been used to increase proliferation of NSPCs and attempt to
increase their contribution to neural repair. This has led to mixed
results, depending upon the injury/disease model used and pos-
sibly the species in which it was examined. EGF infusion for 6
days into the normal adult mouse forebrain increased the num-
ber of NSPCs at the SVZ, promoted their migration into the
parenchyma (cortex, striatum, and septum), and resulted in 25%
surviving for at least 7 weeks; however the majority of cells that
differentiated were astrocytes with a small percentage of neu-
rons and oligodendrocytes (Craig et al., 1996). Indeed, generally,
EGF tends to promote an astroglial rather than neuronal fate, at
least in rats (Kuhn et al., 1997). However, in mice, infusion of
EGF into the lateral ventricles of the uninjured brain similarly
increased SVZ NSPC proliferation and induced their migration
into surrounding parenchyma, but most of the cells adopted an
oligodendroglial fate, with a smaller percentage astroglial. This
was further enhanced following a demyelinating lesion of the
corpus callosum (Gonzalez-Perez et al., 2009). These cells may
be a sub-population of SVZ NSPCs, the NG2+ oligodendrocyte
progenitors, which express EGFR and are induced to migrate in
response to EGF (Aguirre et al., 2005, 2007).
Conversely, in the damaged brain, such as following ischemia,
EGF promoted SVZ NPC proliferation with subsequent pro-
duction of neuroblasts in SVZ and striatum (Ninomiya et al.,
2006), also it induced migration of doublecortin positive pre-
cursors and their subsequent long term (13 weeks) survival as
parvalbumin-expressing interneurons (Teramoto et al., 2003).
A similar infusion following traumatic brain injury also induced
SVZ proliferation, as well as SGZ proliferation, at early time-
points but did not promote longer term (4 weeks survival) of
the newborn SGZ cells, many of which had differentiated into
astrocytes rather than neurons (Sun et al., 2010). Similarly, in a
rat model of ischemia EGF alone induced proliferation and some
NSPC migration but did not promote regeneration unless com-
bined with a later administration of erythropoietin (Epo) (Kolb
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et al., 2007), with similar results obtained for infusion of TGFα in
a PD model (Cooper and Isacson, 2004). Part of the discrepancy
between differentiation outcomes may lie in rat:mouse species
differences. In general, mouse studies have indicated that EGF
infusion can promote proliferation, migration and at least some
neuronal differentiation while rat studies have shown prolifera-
tion, some migration and differentiation into glial cells, if they
are found to differentiate at all. This may be due to EGF-induced
dysplasia in rat but not mouse SVZ (Lindberg et al., 2012).
In rats, the EGF-induced NSPC proliferative response generates
SVZ/lateral ventricle polyps, which contain a higher percentage
of cells expressing the transcription factors Sox2,Olig2, markers of
proliferative NPCs, as well as Id1, an inhibitor of neuronal differ-
entiation, concomitant with decreased expression of the neurob-
last marker doublecortin. This suggests that in rat, EGF promotes
proliferation of more glial fated NPCs that do not migrate to the
same extent as mouse NPCs exposed to EGF. However, combina-
tion of EGF plus other growth factors appears to overcome some
of the limitations of infusion of EGF alone to some extent.
EGF plus FGF2
FGF2 is another potent NSPCmitogen, commonly used to induce
proliferation of these cells in culture, usually in combination
with EGF. Infusion of FGF2 by itself into the lateral ventricles
of normal adult rats promotes NSPC proliferation and enhances
neurogenesis in the OB (Kuhn et al., 1997). Following trau-
matic brain injury it has been shown to enhance SVZ and SGZ
NSPC proliferation and increase the 4 weeks survival of new-
born neurons (Sun et al., 2009), while FGF2 knockout mice
show decreased hippocampal neurogenesis following seizure or
ischemia (Yoshimura et al., 2001). In addition, conditional dele-
tion of FGFR1, the major receptor for FGF2, decreases hippocam-
pal neurogenesis and impairs memory consolidation (Zhao et al.,
2007). Quite a few studies have used a combination of EGF
and FGF2 infusion, which has generally promoted neural repair.
In a rat global ischemia model, which led to loss of CA1 hip-
pocampal neurons, EGF+FGF2 promoted proliferation of SVZ-
derived cells which repopulated the damaged CA1 hippocampal
neurons and promoted functional recovery (Nakatomi et al.,
2002). Similar studies reported increased numbers of neural pro-
genitors in hippocampus, as well as SVZ and hypothalamus
(Oya et al., 2008). Comparable results were obtained follow-
ing transient middle cerebral artery occlusion in rat, including
increased neuronal numbers and survival (Tureyen et al., 2005).
However, in an endothelin model of transient ischemia, while
co-infusion of EGF+FGF2 promoted increases in SVZ neurogen-
esis, it decreased hippocampal neurogenesis and increased infarct
volumes (Baldauf and Reymann, 2005) but the reasons for the
different outcomes in these models is not clear. Increased pro-
liferation and migration to dopamine deficient areas have also
been observed following EGF+FGF2 infusion in a PD model
(Winner et al., 2008).
Other factors that can promote NSPC proliferation
Although EGF and FGF2 are possibly the most potent NSPC
mitogens, particularly for SVZ-derived cells, other factors can also
promote increases in NSPC numbers, although most have yet to
be tested in brain injury/disease models. Infusion of ATP into the
lateral ventricles of mice increased numbers of transit amplifying
progenitor cells (Suyama et al., 2012). A mechanism by which
this occurs may involve induction of FGF2 and TGF synthesis (Jia
et al., 2011). VEGF can augment SVZ progenitor proliferation, as
well as migration (Wittko et al., 2009; Calvo et al., 2011). Other
factors have been shown to enhance proliferation induced by EGF
and/or FGF2 without having a notable effect by themselves, such
as growth hormone (GH) (McLenachan et al., 2009).
IGFs also play a role in several NSPC functions. IGF1 has
different effects in the SVZ and dentate gyrus SGZ. Peripheral
administration promotes hippocampal dentate gyrus NSPC pro-
liferation and increases subsequent dentate gyrus neurogenesis
(Aberg et al., 2000) and survival (Cheng et al., 2001). GH receptor
knockoutmice, which are serum-IGF1-deficient, do not show any
alterations in hippocampal neurogenesis (Ransome and Turnley,
2008b), which may indicate that local hippocampal/dentate gyrus
production of IGF-1 is important in supporting ongoing hip-
pocampal neurogenesis (Sun et al., 2005a). However, peripheral
administration of GH promoted hippocampal but not SVZNSPC
proliferation (Aberg et al., 2009). Indeed, in the SVZ IGF1 does
not seem to regulate proliferation, rather being more impor-
tant for NSPC migration; IGF1 null mice show an abundance
of neuroblasts in the SVZ that have failed to migrate to the OB
(Hurtado-Chong et al., 2009). IGF2 regulates proliferation in
the dentate gyrus in an Akt-dependent manner (Bracko et al.,
2012) and promotes survival of newborn hippocampal neu-
rons as well as regulating hippocampal dependent fear extinction
(Agis-Balboa et al., 2011).
NEUROTROPHINS
Neurotrophin signaling mediated by BDNF interacting with TrkB
receptors and to a much lesser extent NGF binding to TrkA, reg-
ulates several aspects of NSPC function. In the adult brain, TrkB
expression and effects of BDNF are widespread but TrkA expres-
sion is very limited, primarily restricted to basal forebrain cholin-
ergic neurons which project to the NGF-expressing hippocampus.
Therefore, effects of BDNF in NSPC biology have been the
most widely studied, although NGF infusion has been shown
to promote the survival of normal newborn dentate granule cell
neurons but not proliferation of their progenitors (Frielingsdorf
et al., 2007). Intranasal delivery of NGF following focal ischemia
in rats similarly did not promote proliferation of SVZ progeni-
tors but enhanced subsequent newborn neuronal survival in the
ipsilateral SVZ and injured striatum (Zhu et al., 2011).
In vitro, SVZ-derived neurospheres express TrkB and little/no
TrkA or TrkC and addition of BDNF promoted a transient
increase in newborn neuron numbers due to enhanced differenti-
ation and neurite outgrowth, rather than a proliferative effect on
the NSPCs (Ahmed et al., 1995). Further, BDNF is required for
cultured hippocampal progenitor cells to adopt a neuronal fate
(Bull and Bartlett, 2005).
In the dentate gyrus, TrkB is expressed predominantly by
maturing but not proliferating neuroblasts (Donovan et al.,
2008), which correlates with findings that BDNF is important for
neuroblast migration, survival, and integration of new neurons.
BDNF increases the number and survival of newborn neurons
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in the SVZ and OB (Kirschenbaum and Goldman, 1995; Zigova
et al., 1998; Bath et al., 2008), in a p75 neurotrophin receptor-
dependent manner (Young et al., 2007), and in striatum, caudate
putamen and septum (Benraiss et al., 2001; Henry et al., 2007),
dentate gyrus (Lee et al., 2002) as well as subcallosal neurons (Kim
et al., 2011b). Knockdown of TrkB receptors and disruption of
BDNF signaling resulted in decreased SGZ NSPC proliferation
and neurogenesis, indicating that TrkB signaling may also have
some proliferative effects in these cells (Li et al., 2008). Disruption
of BDNF signaling also results in shorter dendrites and reduced
spine formation, culminating in a lack of survival of newborn
granule cells (Bergami et al., 2008; Gao et al., 2009a). In addi-
tion, conditional deletion of BDNF resulted in increased death of
newborn neurons in mice following traumatic brain injury (Gao
and Chen, 2009). However, conversely, enhanced long-term AAV-
mediated BDNF expression in the hippocampus was shown to
inhibit neurogenesis following ischemia in rats (Larsson et al.,
2002). The reason for this discrepancy is unclear and further work
is required to delineate the mechanisms by which BDNF reg-
ulates adult neurogenesis following neural damage. Given that
neural activity promotes BDNF-mediated TrkB activation (Aloyz
et al., 1999) and TrkB signaling is required for activity-dependent
differentiation of hippocampal NSPCs, BDNF is likely to be a
critical factor to promote NSPC-derived newborn neuron sur-
vival and integration into neural circuitry. However, if too much
BDNF-stimulation is provided, this may be at the expense of
NSPC numbers in some situations but this needs further study
for confirmation.
BDNF combined with a mitogen is more effective in enhanc-
ing NSPC function and may be a better therapeutic option.
Neurogenic NSPCs can be cultured from SVZ of adult humans
but requires a combination of FGF2 and BDNF for robust
growth (Pincus et al., 1998). This combination also appears to
be required for creating a neurogenic environment in normally
non-neurogenic regions in vivo (Chen et al., 2007a). In addi-
tion, co-infusion of BDNF plus EGF was more effective than
either factor alone at promoting long term striatal neuron survival
following ischemic injury in mice (Im et al., 2010).
MORPHOGENS
The morphogens Wnt, Shh, and Bone Morphogenic Proteins
(BMPs) play a major role in neural development with some data
to suggest theymay also play a role in the NSPC response to neural
damage.
Wnt signaling
While Wnts are endogenously expressed in adult neurogenic
niches (Wexler et al., 2009), their expression is not upregulated
following neuronal damage, such as stroke (Morris et al., 2007).
Wnt signaling via β-catenin, promotes NSC proliferation to reg-
ulate their maintenance (Lie et al., 2005; Adachi et al., 2007).
This appears to be by regulating symmetric vs. asymmetric divi-
sion, promoting symmetric division during neural regeneration
(Piccin and Morshead, 2011). Wnt signaling is negatively regu-
lated by glycogen synthase kinase 3 beta (GSK3β) and inhibitors
of GSK3β have been proposed as candidate targets for neural
repair (Mao et al., 2009). Inhibition of β-catenin signaling by
the amyloid beta peptide resulted in reduced neurogenesis from
NPCs grown from Alzheimer disease brains, which also have
increased levels of GSK3β (He and Shen, 2009). Further, down-
regulation of β-catenin in a rat stroke model inhibited striatal
neurogenesis (Lei et al., 2008), while overexpression of Wnt3a
following focal ischemia promoted NSPC proliferation, neuro-
genesis and functional recovery (Shruster et al., 2012). However,
following traumatic brain injury in mice, β-catenin activity was
upregulated in cortical NG2+ oligodendrocyte/astrocyte progeni-
tor cells, suggesting that it also plays a role in gliogenesis following
injury (White et al., 2010).
Shh
Intrathecal administration of Shh to rats following ischemia pro-
moted SVZ NSPC proliferation and improved behavioral recov-
ery (Bambakidis et al., 2012), while following spinal cord injury
it promoted proliferation of nestin+ NSPCs surrounding the
central canal leading to increased numbers of oligodendrocyte
precursors and neurons (Bambakidis et al., 2003). Shh expression
is upregulated in the SVZ and hippocampus following ischemia,
potentially playing a role in increased proliferation in a Notch
dependent manner (Sims et al., 2009; Wang et al., 2009); how-
ever in the hippocampus its expression was also upregulated in
mature CA3 neurons, suggesting effects in mature neurons as
well as progenitors (Sims et al., 2009). The source of Shh in
the adult brain appears to be astrocytes. In the normal brain,
astrocytes in neurogenic regions produce Shh and when trans-
planted they induce neurogenesis in non-neurogenic regions
of the brain, such as cortex (Jiao and Chen, 2008). Following
brain injury activated astrocytes upregulate Shh expression in
response to pro-inflammatory stimuli, which subsequently pro-
motes increased numbers of Olig2+ NSPCs (Amankulor et al.,
2009); this may be via activation of quiescent endogenous corti-
cal NSPCs derived from astrocytes (Ahmed et al., 2012). However,
in different neuroinflammatory conditions, such as experimental
allergic encephalomyelitis (EAE) or multiple sclerosis, the inflam-
matory response induces Shh in astrocytes as above but inhibits
Shh-induced NSPC differentiation by subsequent downregula-
tion of the Gli1 transcription factor (Wang et al., 2008).
Bone morphogenic proteins (BMPs)
The role of BMP signaling in NSPCs and their role following
CNS injury has recently been reviewed (Sabo et al., 2009) and
so will only be covered briefly here. In general, BMP signaling
inhibits neuronal and oligodendroglial differentiation of NPCs
and promotes astrogliogenesis, during development (Gross et al.,
1996) and in the adult (Lim et al., 2000), with somewhat different
effects at different stages of development (Mehler et al., 2000).
However, expression of the BMP inhibitor noggin in the SVZ
(Lim et al., 2000) or SGZ (Bonaguidi et al., 2008) can obstruct
this cascade and promote neurogenesis. Further, BMP signaling
promotes non-neurogenic parenchymal astroglial cell fate while
leukemia inhibitory factor (LIF), which also promotes astroglio-
genesis, promotes cells of an astroglial progenitor cell phenotype
(Bonaguidi et al., 2005). Demyelination induced expression of the
BMP antagonist chordin in the SVZ, induced glial fate in neu-
roblasts to generate new oligodendrocytes in the corpus callosum
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(Jablonska et al., 2010). Conversely, BMP signaling in SVZ NSCs
but not NPCs is required to promote a neurogenic rather than
oligodendrogliogenic cell fate (Colak et al., 2008).
BMP signaling inhibits NPC proliferation (Gajera et al., 2010)
and while inhibition of the BMP pathway increases neurogenesis
initially, it eventually results in depletion of the NSC pool, leading
to decreased neurogenesis in the dentate gyrus (Mira et al., 2010).
This indicates that a fine balance of BMP signaling vs. inhibition
is required to regulate appropriate NSC numbers and subsequent
cell fate.
Given that BMP signaling promotes an astroglial fate and
inhibits oligodendrogliogenesis and neurogenesis, the effect of
inhibition of BMP signaling by infusion of noggin into the lat-
eral ventricles has been examined in various models of neural
injury. In cuprizone-induced demyelination models noggin infu-
sion inhibited the cuprizone induced upregulation of BMP4
and its signaling pathways, decreased SVZ astrocyte numbers,
increased oligodendrocyte numbers and promoted remyelination
of the corpus callosum (Cate et al., 2010; Sabo et al., 2011), possi-
bly by regulation of Olig2 function (Chen et al., 2012). Noggin
infusion also produced similar results in a model of intraven-
tricular hemorrhage (Dummula et al., 2011). In a brain injury
model, noggin was found to be produced by reactive astrocytes
and similarly promoted oligodendrocyte fate (Hampton et al.,
2007). It was also recently shown that Bcl2 regulates neurogenesis
in a striatal injury model, by increasing β-catenin expression and
decreasing BMP4 expression, in a noggin independent fashion
(Lei et al., 2012).
ERYTHROPOIETIN (Epo)
Epo is a cytokine better known for its regulation of erythrocyte
production. However it also has a number of functions within
the CNS and on NSPC biology. Epo is expressed in the devel-
oping and adult SVZ (Shingo et al., 2001) and is required for
endogenous embryonic and adult SVZ and SGZ neurogenesis
(Tsai et al., 2006; Chen et al., 2007b). It promotes neurogene-
sis of SVZ NSPCs at the expense of multipotent progenitors in
the normal rodent brain (Shingo et al., 2001) but in the SGZ this
effect is transient, briefly increasing neuronal progenitor numbers
but with no long term enhancement of survival (Ransome and
Turnley, 2007). One of the mechanisms by which it may do this is
by upregulation of Suppressor of Cytokine Signaling-2 (SOCS2)
in NSPCs (Wang et al., 2004b). SOCS2, an intracellular regula-
tor of cytokine signaling, promotes embryonic SVZ neurogenesis
(Turnley et al., 2002; Scott et al., 2006), while in the hippocampus
it promotes NSPC-derived newborn neuron survival (Ransome
and Turnley, 2008b). It also promotes axonal growth of hip-
pocampal neurons (Ransome and Turnley, 2008a), which may
be a factor contributing to its enhanced neuroprotective effects
following neural injury.
Following neural damage Epo has been found to be both
neuroprotective and to promote neurogenesis (Wang et al.,
2004a). Epo expression is induced/upregulated by hypoxia and
thus many studies have examined its role post-ischemia or in
ischemia/hypoxia models, although it has also been shown to
be effective following traumatic brain injury. Conditional knock-
down of the Epo receptor reduced post-stroke neurogenesis, with
reduced proliferation and stroke-induced neuroblastmigration to
the cortex (Tsai et al., 2006). The Epo-induced NSPC migration
appears to be indirect, rather inducing expression of matrix met-
alloproteases in endothelial cells, which in turn induced NSPC
migration (Wang et al., 2006). Peripheral administration of Epo
promotes NSPC proliferation, neurogenesis, oligodendrogenesis,
and neurovascular remodeling following traumatic brain injury
in rats, enhancing functional outcome (Lu et al., 2005; Zhang
et al., 2010; Meng et al., 2011; Ning et al., 2011; Xiong et al., 2011).
Inhibition of proliferation by infusion of AraC into the ventricles
inhibited Epo-induced dentate gyrus neurogenesis and recovery
of spatial learning (Zhang et al., 2012). Epo has also been shown
to be neuroprotective in disease models, such as PD, in which it
promoted SVZNSPC proliferation andmigration to the damaged
striatum (Kadota et al., 2009).
One of the problems associated with use of Epo as a thera-
peutic for promotion of neural regeneration is that it generally
increases the hematocrit at doses required for promotion of neu-
rogenesis (e.g., 5000U/kg). While this has not presented major
issues for use in animal models, it raises concerns for potential
clinical use. Therefore, several Epo derivatives have been devel-
oped to try to promote neuroprotective effects while avoiding
effects on erythrocyte production. Carbamylated Epo does not
bind to classical Epo receptor and does not stimulate erythro-
poiesis but does promote SVZ and dentate gyrus proliferation
and neuronal differentiation of adult NSPCs (Wang et al., 2007;
Leconte et al., 2011), while a different non-erythropoietic deriva-
tive asialo-Epo promoted SVZ-derived oligodendrogenesis (Kako
et al., 2012). A peptide agonist of Epo, Epobis, has also recently
been developed and shown to promote neuron survival and neu-
rite outgrowth, but its effects on neurogenesis have yet to be
determined (Pankratova et al., 2012).
CHEMOKINES AND CYTOKINES
Chemokines form a family of small (8–14 kD), mainly basic,
secreted molecules that are primarily known for regulating
chemoattraction of immune cells to sites of tissue damage.
They have been reported to have widespread non-immunological
effects in the CNS, including regulation of neural cell prolifer-
ation, migration, survival, and synaptic transmission and can
act in a paracrine or autocrine manner (Bajetto et al., 2002;
Cartier et al., 2005).
Pro-inflammatory cytokines, such as interferon gamma
(IFNγ) and tumor necrosis factor alpha (TNFα) appear to
be major regulators of chemokine and chemokine receptor
expression in many tissues (Hiroi and Ohmori, 2003; Suyama
et al., 2005). In the adult brain there is basal expression of
chemokines, especially in neurogenic regions, while treatment
with IFNγ and TNFα can significantly increase the expression
of specific chemokines including CXCL1, CXCL9, and CCL2
(Turbic et al., 2011).
Adult NSPCs express a range of chemokine receptors and
chemokines are expressed in different brain regions, with the
highest levels in the OB, suggesting an as yet largely unex-
plored role for chemokines in regulating basal adult NPC migra-
tion (Turbic et al., 2011). Neurospheres derived from adult
mouse SVZ-derived NPCs have been shown to express a range
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of chemokine receptors, including CCR1-8, 10 and CXCR1-6
(Tran et al., 2004). Functionally, specific chemokines, such as
CXCL12/CXCR4 can promote NPC migration (Imitola et al.,
2004; Tran et al., 2004; Dziembowska et al., 2005) and prolif-
eration (Tran et al., 2004) or survival (Krathwohl and Kaiser,
2004; Dziembowska et al., 2005) in vitro. Following neural dam-
age, NPC migration to site of injury is promoted by CXCL12
(Imitola et al., 2004; Itoh et al., 2009) and is mediated at least
in part, by induction of metalloprotease expression in the NPCs
(Barkho et al., 2008). CCL2, CCL3, and CXCL1 also promote
NPC migration to striatum following quinolinic acid lesion
(Gordon et al., 2009).
The gp130-associated cytokines, ciliary neurotrophic factor
(CNTF) and leukemia inhibitory factor (LIF), activate Janus
kinase [JAK/signal transducer of transcription 3 (STAT3)], mito-
gen activated protein (MAP) kinase and PI-3K/Akt pathways
following ligand binding. These cytokines have been shown
to regulate NSC proliferation and differentiation (Turnley and
Bartlett, 2000; Heinrich et al., 2003; Kamimura et al., 2003; Ernst
and Jenkins, 2004). IFNγ, which signals via STAT1, and IFNβ
which does not, both inhibit cultured adult NPC proliferation,
but only IFNγ promotes neuronal differentiation (Wong et al.,
2004; Lum et al., 2009). Specifically in the dentate gyrus, the
activation of STAT3 from CNTF appears to be essential for the
formation and maintenance of the NSCs (Muller et al., 2009).
OTHER FACTORS THAT PLAY A ROLE IN NSPC FUNCTION
THAT MAY BE TARGETED FOR NEURAL REPAIR
There are factors involved in neurogenesis other than extrinsic
growth factors and cytokines, as discussed above. Some of these
includemembrane boundmolecules, neurotransmitters and their
receptors and blood vasculature.
EPH/EPHRIN SIGNALING AND NSPCs—A NEW TARGET TO PROMOTE
NSPC PROLIFERATION, SURVIVAL, AND MIGRATION
The Eph family of receptor tyrosine kinases and their ligands,
the ephrins, are membrane bound molecules that signal bi-
directionally, are generally involved in cell or axon guidance by
repulsive mechanisms and which play a role following neural
injury (reviewed in Goldshmit et al., 2006b). They have been
receiving increasing interest of late as they have been shown to
play major roles in inhibition of regeneration in the CNS follow-
ing neural injury or disease, with deletion or blocking of various
Ephs or ephrins promoting neural repair (Goldshmit et al., 2004,
2006b, 2011; Rodger et al., 2004; Liu et al., 2006; Fabes et al.,
2007; Overman et al., 2012; Van Hoecke et al., 2012). EphA4 also
plays a role in regulation of inflammation following neural injury
(Munro et al., 2012), which could have secondary effects onNSPC
responses.
Eph receptor signaling also regulates several aspects of
NSPC biology but as yet has not been targeted to enhance
NSPC responses following injury. The EphB2/ephrin-B2 path-
way enables formation of the chain migration from the SVZ to
the OB (Conover et al., 2000) and also controls the conversion
of ependymal cells to astrocytic NSPCs (Nomura et al., 2010).
EphB2 signaling via ephrin-B1 is also required for development of
the dorsal half of the dentate gyrus, where it controls migration of
the dentate progenitor cells (Catchpole and Henkemeyer, 2011).
Ephrin-A2 signaling via EphA7 inhibits SVZ NSPC proliferation
and subsequent neurogenesis (Holmberg et al., 2005), while con-
versely ephrin-A5 signaling via EphA7 induces their apoptosis
(Depaepe et al., 2005). EphB2 and ephrin-B signaling however
promotes SVZ NSPC proliferation, decreases migration, and pro-
motes neuronal differentiation (Katakowski et al., 2005), with
ephrin-B1 expression in SVZ NSPCs critical for maintenance
of the proliferative NSPC state (Qiu et al., 2008), a role also
played by EphA4 (Khodosevich et al., 2011). In addition, EphB3
is expressed by adult SVZ NSPCs and neuroblasts and EphB3
and ephrin-B3 knockout mice show increased neonatal and adult
SVZ NSPC proliferation, indicating that this pathway normally
inhibits their proliferation (Theus et al., 2010; Del Valle et al.,
2011; Doeppner et al., 2011). Infusion of soluble ephrin-B3 into
the lateral ventricles reversed the proliferation defect in ephrin-
B3 knockout mice but not the EphB3 receptor knockout mice
(Theus et al., 2010).
In the hippocampus, EphB1 and ephrin-B3 promote hip-
pocampal NSPC proliferation and migration, as well as cell
polarity (Chumley et al., 2007), while ephrin-A5 promotes hip-
pocampal NSPC proliferation and neurogenesis, at least partly
through regulation of the normal vascular system (Hara et al.,
2010), which requires normal EphA4 (Goldshmit et al., 2006a)
and EphB4 signaling (Colin-Castelan et al., 2011). Ephrin-B2,
expressed by hippocampal astrocytes in the SGZ, induces neu-
ronal differentiation of EphB4-expressing hippocampal NSPCs
and this effect involves activation of β-catenin independent of
Wnt signaling, with subsequent upregulation of proneural tran-
scription factors (Ashton et al., 2012).
To date, little has been examined regarding the role of
Eph/ephrin signaling following neural damage. Following trau-
matic brain injury, EphB3 expression was transiently downreg-
ulated, which may lift its inhibition of NSPC proliferation and
this may be one of the mechanisms by which NSPCs are able
to respond to injury, by increasing proliferation and survival
(Theus et al., 2010). However, in ephrin-B3 knockout mice,
while there was an increase in NSPC proliferation following
ischemic injury, there was also enhanced cortical damage with an
increased infarct volume (Doeppner et al., 2011) due to NSPC-
independent effects of ephrin-B3, which will need to be taken
into account when considering therapeutic use of Eph/ephrins.
Conversely, in a model of PD infusion of soluble ephrin-A1
into the lateral ventricles, to activate EphA receptor/s, promoted
SVZ NSPC proliferation and migration of these cells to striatum,
where they subsequently differentiated in dopaminergic neurons
(Jing et al., 2012).
OTHER FACTORS
Following injury, one of the early mediators of the injury response
is upregulation of nitric oxide (NO). NO has been reported
to have proliferative (Zhang et al., 2001a; Reif et al., 2004) or
anti-proliferative (Packer et al., 2003; Park et al., 2003; Moreno-
Lopez et al., 2004) effects on basal SVZ and SGZ NSPCs,
as well as following injury (Zhang et al., 2001a; Zhu et al.,
2003; Sun et al., 2005b). This apparent discrepancy in effect
appears to lie largely in the source of NO production and the
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subsequent signaling pathways induced. If the NO derives from
neuronal nitric oxide synthase (nNOS) then the effect is largely
anti-proliferative (Packer et al., 2003; Moreno-Lopez et al., 2004;
Sun et al., 2005b), but if derived from inducible NOS (iNOS)
(Zhu et al., 2003; Carreira et al., 2010) or endothelial derived
NOS (eNOS) (Reif et al., 2004) then the effects are largely pro-
liferative. This likely relates to the location of NOS as well as
the concentration of NO produced. Further, infusion of NO
donors that induce MAP kinase signaling (Carreira et al., 2010)
or cyclic guanosine monophosphate (cGMP) signaling, pro-
motes proliferation and neurogenesis in normal and ischemic
rats (Zhang et al., 2001a). Indeed, both pathways appear to be
involved in NSPC proliferation in response to NO, with acti-
vation of the MAPK pathway at shorter timepoints (6 h) and
activation of cGMP at later timepoints (24 h) (Carreira et al.,
2012). Recent work has indicated that the NO-cGMP pathway
is also an important mediator of the neuro-proliferative effects
of other factors, such as Neuropeptide Y in the hippocampus
(Howell et al., 2005; Agasse et al., 2008; Cheung et al., 2012)
and also explains the increased proliferation and neurogenesis
observed with infusion of phosphodiesterase inhibitors, such as
sildenafil and tadalafil, which lead to increased cGMP levels and
improve outcome in stroke models (Zhang et al., 2003, 2006).
cGMP levels also appear to regulate NSPC fate during embryonic
development, with high levels promoting neuronal differenti-
ation and low levels non-neuronal fate (Gomez-Pinedo et al.,
2010), however, whether this is the case in adult remains to be
determined.
Endocannabinoid signaling has been shown to regulate migra-
tion and neurogenesis in both the SVZ and dentate gyrus (Aguado
et al., 2005, 2007; Jiang et al., 2005; Goncalves et al., 2008;
Gao et al., 2010; Hill et al., 2010; Wolf et al., 2010; Oudin
et al., 2011a,b). Other molecules involved in NPC migration
include polysialated neural cell adhesion molecule (PSA-NCAM)
(Cremer et al., 1994; Hu et al., 1996; Chazal et al., 2000), Slit-
Robo (Wu et al., 1999), and integrins (Jacques et al., 1998; Murase
and Horwitz, 2002). In basal conditions, reelin is a detachment
signal for neuroblasts from the RMS at the OB (Hack et al.,
2002), while overexpression of reelin in a demyelinating lesion
led to an increase in ectopic migration of neuroblasts at the
lesion site (Courtes et al., 2011). Many of these factors signal
via the Rho kinase pathway, which is a downstream regula-
tor of NPC migration (Leong et al., 2011) and targeting this
pathway may circumvent the large number of external signals
that converge on this pathway to allow more precise control of
directed NPC migration and possibly neuronal differentiation
and survival. In the brain parenchyma NSPCs interact with blood
vessels in the neurovascular niche (Shen et al., 2008; Tavazoie
et al., 2008), neuroblasts can migrate along blood vessels (Honda
et al., 2007) and use vessels to migrate radially into the cortex
(Le Magueresse et al., 2012). Following ischemia SVZ neuroblasts
migrate to the infarct in close association with blood vessels
(Ohab et al., 2006; Yamashita et al., 2006; Thored et al., 2007;
Kojima et al., 2010).
NMDA receptors expressed in neuroblasts along the RMS are
crucial to the integration of these neurons in existing OB circuitry
(Platel et al., 2010), with glutamate released from astroglial cells
in the glial tube that surrounds the migrating neuroblasts. NMDA
receptor activation in newly born dentate gyrus granule cells
also increases survival. Initial GABA depolarization promotes
maturation of neurons in the dentate gyrus and OB (Saghatelyan
et al., 2005; Ge et al., 2006) and this depolarization and sub-
sequent Ca2+ influx are required for dendrite initiation and
elongation (Gascon et al., 2006). Agrin signaling is also nec-
essary for integration and survival of newborn neurons in the
OB: a loss of agrin leads to improper synapse formation while
overexpression of agrin results in an increase in dendritic spines
(Burk et al., 2012).
The migration distance for new neurons from the SGZ is rel-
atively short as they travel into the granular layer above the SGZ,
where guidance molecules may control this movement. NMDA
receptor signaling is required for the proper migration of new-
born granular cells in the dentate gyrus (Namba et al., 2011). This
is achieved through the activation of Disrupted-in-schizophrenia
(DISC1), as neurons without DISC1migrate further into granular
layer and into themolecular layer (Duan et al., 2007; Namba et al.,
2011). DISC1 also controls the dendritic maturation of newborn
granule cells through GABA depolarization of NKCC1 and acti-
vation of the Akt-mTOR pathway (Duan et al., 2007; Kim et al.,
2012), while Reelin regulates migration and dendritic develop-
ment of adult-generated hippocampal neurons (Teixeira et al.,
2012). Whether targeting any of the above factors will enhance
NSPC responses following neural injury largely remains to be
determined.
CONCLUSIONS
Many factors regulate the biology of NSPCs at different stages
along their growth and maturation cycle. To date, the majority
of studies which have administered extrinsic growth factors or
cytokines have concentrated on the effect of a single factor at
a time. However, some studies are now emerging where combi-
natorial effects of different factors have been examined. It will
not be sufficient to only increase the number of NSPCs pro-
duced by administration of a mitogen. While this can indeed
increase neurogenesis, the number of surviving and functionally
integrated neurons (or oligodendrocytes) is still very limited. It
would be prudent to combine use of mitogens with other fac-
tors that enhance neurogenesis or oligogliogenesis respectively, as
well as factors that enhance their subsequent survival and inte-
gration. Which factors are chosen to combine will likely depend
on the injury or disease model to be examined, whether neu-
rons and/or oligodendrocytes need to be replaced and may also
be species dependent to a certain extent, although the combi-
nation of a mitogen such as EGF and a survival factor, such
as BDNF may be generally beneficial. Some factors, such as
Epo, have multiple actions, including NSPC proliferation, neu-
ronal differentiation, and oligodendrocyte maturation, as well as
being neuroprotective, which makes them particularly attractive
as potential therapeutics for treatment of the damaged brain.
Most of the work described above was conducted in rodents and
to date little work has been performed following neural injury
in brains of gyrencephalic species, such as non-human primates
(Tonchev et al., 2003a,b, 2005, 2007). Sheep models are also being
developed to allow such questions to be answered in a model
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more relevant to human brain damage (e.g., Wells et al., 2012).
Human clinical trials are also underway to test therapeutic effec-
tiveness of a range of extrinsic factors, such as Epo, following
brain injury. For a complete list see www.clinicaltrials.gov. Two
decades since their discovery in mammalian brains, facilitation
of the NSPC response to brain damage by administration of
extrinsic factors still holds great promise of therapeutic potential,
although much ground still remains to be covered.
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